IVF study finds shorter insemination protects embryo availability without harming success

New IVF evidence suggests shorter insemination may ease laboratory challenges and reduce cancelled cycles without sacrificing live birth success, offering potential reassurance for patients with limited oocyte yield.

Study: Short-term vs. overnight insemination: which one is better for patients with only one or two oocytes retrieved in IVF cycles? Image Credit: Rohane Hamilton / Shutterstock

Study: Short-term vs. overnight insemination: which one is better for patients with only one or two oocytes retrieved in IVF cycles? Image Credit: Rohane Hamilton / Shutterstock

In a recent study published in the journal Frontiers in Endocrinology, researchers compared short-term and overnight insemination methods during in vitro fertilization (IVF) cycles, in which one or two oocytes were retrieved. The primary outcome was cumulative live birth, defined as the first live birth achieved from all embryos generated from a single oocyte retrieval cycle.

Clinical Context: Infertility and Low Oocyte Numbers

Globally, nearly one in six couples experience infertility, and IVF has become a cornerstone of treatment. However, not all IVF cycles are equivalent. Patients producing only one or two oocytes, representing cycles with limited oocyte yield rather than strictly defined poor ovarian response, experience higher rates of cycle cancellation, emotional distress, and financial burden. Although the emotional impact of cycle cancellation is well recognised in clinical practice, it was not directly assessed in this study.

In conventional IVF, oocytes and sperm are co-incubated overnight, exposing them to prolonged oxidative stress that may theoretically impair embryo development, although this mechanism remains inferential. Short-term insemination involves removing cumulus–oocyte complexes from sperm co-incubation after several hours and has been adopted in some laboratories. However, its clinical utility in cycles with very limited oocyte numbers remains uncertain, particularly with respect to meaningful outcomes such as cumulative live birth rate.

Study Design and Patient Selection

This retrospective cohort study was conducted at a single reproductive medicine centre and included patients undergoing IVF treatment between January 2013 and December 2022. Only cycles retrieving one or two oocytes that resulted in either a live birth or exhaustion of all embryos from that retrieval were included. Patients with uterine abnormalities, intrauterine adhesions, or prior caesarean scar diverticulum were excluded.

Insemination Protocols and Laboratory Procedures

Cycles were classified according to insemination duration. Short-term insemination involved five hours of sperm–oocyte co-incubation, while overnight insemination involved approximately 17 hours. Semen preparation and assessment were performed in accordance with World Health Organization recommendations, using density gradient centrifugation and swim-up techniques.

Normal fertilization was defined by the presence of two pronuclei, assessed approximately 17 ± 1 hours after insemination. Embryos were cultured either to the cleavage stage or to the blastocyst stage, depending on clinical strategy.

Statistical Methods and Outcome Definition

Propensity score matching was used to balance baseline characteristics, including age, ovarian reserve, stimulation parameters, and sperm quality. Associations between insemination strategy and cumulative live birth rate were evaluated using multivariable regression models. Cumulative live birth was defined as the first live birth occurring from all embryos generated during a single oocyte retrieval cycle.

Overall Results and Primary Outcome

A total of 2,392 IVF cycles with one or two oocytes retrieved were analysed. Of these, 2,057 cycles used short-term insemination and 335 used overnight insemination. After propensity score matching, baseline characteristics between groups were well balanced.

Cumulative live birth rates were similar between short-term and overnight insemination, both before and after matching. These findings indicate that reducing sperm–oocyte exposure time did not compromise cumulative live birth outcomes. Although short-term insemination improved certain fertilization and embryo parameters, these improvements did not translate into a statistically significant increase in overall live birth rates. Multivariable analyses confirmed the absence of an adverse effect of short-term insemination on cumulative live birth.

Intermediate Clinical Outcomes and Cycle Continuity

Differences emerged when examining intermediate clinical outcomes. Short-term insemination was associated with lower embryo transfer cancellation rates, fewer cycles with no embryos available, and reduced freeze-all cycle rates. These outcomes are clinically relevant, as cycle cancellation is frequently reported by patients as one of the most emotionally challenging aspects of IVF, although emotional outcomes were not directly measured in this study.

Laboratory Fertilization and Embryo Metrics

Laboratory outcomes favoured short-term insemination. Normal fertilization rates were higher, while the incidence of multiple pronuclei, an indicator of abnormal fertilization, was lower compared with overnight insemination. These findings are consistent with hypotheses of reduced oxidative or mechanical stress during fertilization, although causality cannot be inferred from this retrospective design.

Subgroup Analysis: Blastocyst Culture

In a subgroup analysis of patients whose embryos were cultured to the blastocyst stage, short-term insemination was associated with a numerically higher cumulative live birth rate than overnight insemination. Although crude differences after matching were not statistically significant, adjusted analyses showed lower odds of live birth with overnight insemination. Interaction testing suggested only borderline evidence of effect modification after matching.

Short-term insemination was also associated with fewer delayed-forming blastocysts, which are generally considered less favourable for transfer, although not categorically of poor quality.

Interpretation of Findings

Overall, the findings suggest that although cumulative live birth outcomes were comparable, short-term insemination may confer practical advantages by increasing embryo availability and reducing the risk of cycle failure. These intermediate benefits may have meaningful implications for patient experience and treatment continuity, even though the primary endpoint remained unchanged.

Conclusions and Clinical Implications

In IVF cycles, retrieving only one or two oocytes, short-term insemination achieved cumulative live birth rates comparable to overnight insemination without compromising overall success. Importantly, it reduced embryo transfer cancellations and improved several laboratory indicators of embryo quality.

For patients already facing the physical, emotional, and financial challenges associated with limited oocyte yield, reducing the risk of cycles with no embryos available may be clinically meaningful. These findings support short-term insemination as a viable and potentially advantageous strategy, particularly when blastocyst culture is planned. However, interpretation should consider the retrospective, single-centre design, temporal changes in insemination practices, and laboratory-specific factors that may limit generalisability.

Journal reference:
Vijay Kumar Malesu

Written by

Vijay Kumar Malesu

Vijay holds a Ph.D. in Biotechnology and possesses a deep passion for microbiology. His academic journey has allowed him to delve deeper into understanding the intricate world of microorganisms. Through his research and studies, he has gained expertise in various aspects of microbiology, which includes microbial genetics, microbial physiology, and microbial ecology. Vijay has six years of scientific research experience at renowned research institutes such as the Indian Council for Agricultural Research and KIIT University. He has worked on diverse projects in microbiology, biopolymers, and drug delivery. His contributions to these areas have provided him with a comprehensive understanding of the subject matter and the ability to tackle complex research challenges.    

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Kumar Malesu, Vijay. (2026, February 04). IVF study finds shorter insemination protects embryo availability without harming success. News-Medical. Retrieved on February 04, 2026 from https://www.news-medical.net/news/20260204/IVF-study-finds-shorter-insemination-protects-embryo-availability-without-harming-success.aspx.

  • MLA

    Kumar Malesu, Vijay. "IVF study finds shorter insemination protects embryo availability without harming success". News-Medical. 04 February 2026. <https://www.news-medical.net/news/20260204/IVF-study-finds-shorter-insemination-protects-embryo-availability-without-harming-success.aspx>.

  • Chicago

    Kumar Malesu, Vijay. "IVF study finds shorter insemination protects embryo availability without harming success". News-Medical. https://www.news-medical.net/news/20260204/IVF-study-finds-shorter-insemination-protects-embryo-availability-without-harming-success.aspx. (accessed February 04, 2026).

  • Harvard

    Kumar Malesu, Vijay. 2026. IVF study finds shorter insemination protects embryo availability without harming success. News-Medical, viewed 04 February 2026, https://www.news-medical.net/news/20260204/IVF-study-finds-shorter-insemination-protects-embryo-availability-without-harming-success.aspx.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Study finds increased rates of DNA mutations in mice pups conceived with IVF